Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Oct;13(5):187-90.
doi: 10.3390/curroncol13050018.

Comparing the results of bisphosphonate use in clinical trials with actual practice: a case of apples and oranges?

M C Gainford, G Dranitsaris, W Ooi, M Vanhuyse, M Clemons

Comparing the results of bisphosphonate use in clinical trials with actual practice: a case of apples and oranges?

M C Gainford et al. Curr Oncol. 2006 Oct.
No abstract available

Keywords: Bisphosphonates; bone metastases; breast cancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Kohno N, Aogi K, Minami H, et al. Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized placebo controlled trial. J Clin Oncol. 2005;23:3314–21. - PubMed
    1. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987;55:61–6. - PMC - PubMed
    1. Hill ME, Richards MA, Gregory WM, Smith P, Rubens RD. Spinal cord compression in breast cancer: a review of 70 cases. Br J Cancer. 1993;68:969–73. - PMC - PubMed
    1. Clemons M. Should all breast cancer patients with symptomatic bone metastases be treated with bisphosphonates? The case in support. Clin Oncol (R Coll Radiol) 2004;16:108–11. - PubMed
    1. Gainford MC, Dranitsaris G, Clemons M. Recent developments in bisphosphonates for patients with metastatic breast cancer. BMJ. 2005;330:769–73. - PMC - PubMed

LinkOut - more resources